Bill Texts: LA HB403 | 2023 | Regular Session
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Bill Drafts
Revision | Date | Format | Source | View |
---|---|---|---|---|
Chaptered | Not Avail | Link | View | |
Enrolled | Not Avail | Link | View | |
Engrossed | Not Avail | Link | View | |
Introduced | Not Avail | Link | View |
Amendments
Amendment | Date | Disposition | Format | Source | View |
---|---|---|---|---|---|
No bill amendments currently on file for Louisiana HB403 |
Supplemental Documents
Title | Description | Date | Format | Source | View |
---|---|---|---|---|---|
Analysis | Digest of HB403 Original | Not Avail | Link | View | |
Analysis | Digest of HB403 Engrossed | Not Avail | Link | View |